NCT01147718View on ClinicalTrials.gov

A Drug Interaction Study of Albiglutide and Digoxin

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 11, 2010

Primary Completion Date

November 29, 2010

Study Completion Date

November 29, 2010

Conditions
Diabetes Mellitus, Type 2
Interventions
BIOLOGICAL

digoxin plus albiglutide

A single dose of 0.5mg digoxin on Day 1 followed by 5 weekly doses of subcutaneous albiglutide, followed by a single dose of 0.5mg digoxin on Day 38.

Trial Locations (1)

78744

GSK Investigational Site, Austin

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01147718 - A Drug Interaction Study of Albiglutide and Digoxin | Biotech Hunter | Biotech Hunter